Loading...
XASX
COH
Market cap5.25bUSD
Jun 18, Last price  
114.29AUD
1D
2.67%
1Q
-30.57%
Jan 2017
-6.74%
Name

Cochlear Ltd

Chart & Performance

D1W1MN
XASX:COH chart
P/E
19.22
P/S
3.19
EPS
5.95
Div Yield, %
3.76%
Shrs. gr., 5y
1.87%
Rev. gr., 5y
11.62%
Revenues
2.34b
+4.81%
452,260,000559,412,000601,725,000694,699,000734,803,000809,646,000778,996,000752,721,000804,936,000925,630,0001,130,552,0001,253,800,0001,363,700,0001,426,700,0001,352,300,0001,493,300,0001,641,100,0001,955,700,0002,235,600,0002,343,100,000
Net income
389m
+9.00%
80,032,000100,131,000115,234,000130,540,000155,152,000180,114,00056,803,000132,563,00093,709,000145,840,000188,921,000223,616,000245,800,000276,700,000-238,300,000326,500,000289,100,000300,600,000356,800,000388,900,000
CFO
238m
-38.89%
51,555,00076,836,00084,548,000146,628,000179,546,000201,277,000168,280,00069,727,000111,417,000188,701,000185,113,000259,800,000258,100,000296,000,000-157,800,000265,399,999376,500,000362,400,000388,800,000237,600,000
Dividend
Sep 18, 20252.15 AUD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Cochlear Limited is a global healthcare company specializing in advanced auditory solutions. It develops and manufactures surgically implanted hearing devices for individuals of all ages, from children to adults, across the world. The company's diverse product range features cochlear implant systems, enhanced sound processor upgrades, bone conduction technology, and a variety of complementary accessories and related items. Founded in 1981, Cochlear Limited is headquartered in Sydney, Australia.
URL
https://www.cochlear.com/sg/en/home
IPO date
Dec 04, 1995
Employees
4,800
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT